Saturday, August 30, 2014 12:41:34 PM
http://www.covalon.com/press-release/59/covalon-announces-major-license-and-distribution-agreement-with-molnlycke-health-care
There is a royalty stream, but Covalon will still oversee the production of the product through their contract manufacturer, which should allow for greater profits overall.
I believe the greater issue last quarter was that Molnlycke hadn't even "debuted" the product to the market until the end of the quarter. Investors expecting an immediate boost to sales have unrealistic expectations IMO, sales growth for these products isn't going to be instantaneous; but hopefully slow and steady over the long term.
JMHO.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM